'Gamma brahcytherapy' presentation slideshows

Gamma-1: Five Year Follow-up Vascular Gamma Brachytherapy vs placebo for In-stent Restenosis in Native Coronary Lesions

Gamma-1: Five Year Follow-up Vascular Gamma Brachytherapy vs placebo for In-stent Restenosis in Native Coronary Lesions. MACE: Death, MI or TLR at 5 years. p = 0.380. p = 0.254. p = 0.064. %. p = 1.000. Gamma-1: Five Year Follow-up.

142 views • 2 slides